Cervix carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
HLA-B*15 showed a negative association with HPV-16-positive CaCx (0.1, 0.01), whereas DRB1*04 exhibited protection to both HPV-16-positive CaCx and persistent HPV-16 infection (0.3, 0.0001 and 0.1, 0.0002, respectively).
|
31800372 |
2019 |
Cervix carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
Human Leukocyte Antigen (HLA) Class II -DRB1 and -DQB1 Alleles and the Association with Cervical Cancer in HIV/HPV Co-Infected Women in South Africa.
|
31258717 |
2019 |
Cervix carcinoma
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Further, protective associations were evidenced for alleles B*35 and DRB1*10 and haplotypes A*11-B*35 and DRB1*10-DQB1*0501 with cervical cancer in South India.
|
27268619 |
2016 |
Cervix carcinoma
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Human leukocyte antigen class II DRB1*1302 allele protects against cervical cancer: At which step of multistage carcinogenesis?
|
26235935 |
2015 |
Cervix carcinoma
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Haplotype analysis highlighted the significant association of HLA- DRB1*07:01-DQB1*02:02 and HLA DRB1*10:01-DQB1*05:01 with cervical cancer, while HLA-DRB1*14:04-DQB1*05:03 and DRB1*15:01-DQB1*06:01 conferred decreased risk for cervical cancer.
|
25673541 |
2014 |
Cervix carcinoma
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Among the 25 specific alleles, six (DRB1*0301, *0403,*0404, *0803, *1312 and *1502) were associated with an increased risk cervical cancer in all studies.
|
24551099 |
2014 |
Cervix carcinoma
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Variation in LD between the classic HLA loci, rs9272143 and rs67841474 between populations may explain the different associations of HLA-B*07 and DRB1*1501-DQB1*0602 with cervical cancer between studies.
|
24520070 |
2014 |
Cervix carcinoma
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
We also confirmed previously reported associations of B*0702 and DRB1*1501-DQB1*0602 with susceptibility to and DRB1*1301-DQA1*0103-DQB1*0603 with protection against cervical cancer.
|
23482656 |
2013 |
Cervix carcinoma
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Consistent associations across other studies in women with CC and infected by HPV16 were observed for HLA-DRB1*15 (OR, 3.9; 95% CI, 1.6-10.2) and the haplotype DRB1*15 DQB1*0602 (OR, 4.1; 95% CI, 1.4-12.7) compared with control women.
|
19820376 |
2009 |
Cervix carcinoma
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
The DRB1*13 allele/DRB1*13-DQB1*06 haplotype was strongly protective against risk to HPV infection (p(c) < 0.002) as well as cervical cancer (p(c) 0.01).
|
19272325 |
2009 |
Cervix carcinoma
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
In a similar fashion, the occurrence of DRB1 *13-DQB1 *06 (OR, 0.17; 95% CI, 0.04-0.80) haplotype was significantly lower in the study patients compared with the controls and may confer a decreased risk of CC among Han race population in the Guangdong Province of China.
|
19027490 |
2008 |
Cervix carcinoma
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Accordingly, a specific MHC class II haplotype, DRB1*0901-DQB1*03032, may be a risk factor for cervical carcinoma in the Japanese population.
|
17433060 |
2008 |
Cervix carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
These results indicate that HLA-DPB1*1301 may confer susceptibility to cervical cancer, and the haplotypes DRB1*150101-DQB1*0602 and DRB1*070101-DQB1*0201 may contribute to the resistance to the development of cervical cancer among Chinese women.
|
17349874 |
2007 |
Cervix carcinoma
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
We find that carriers of the commonly reported protective DRB1*1301 and DQB1*0603 alleles have lower HPV 18/45 load compared to noncarriers and a lower risk of developing HPV 18/45-positive cervical carcinoma.
|
15906352 |
2005 |
Cervix carcinoma
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
The strongest class II effects are coming from the DQB1 and DRB1 loci, but the DPB1 locus also contributes to the susceptibility to cervical cancer.
|
15238505 |
2004 |
Cervix carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
Observations from this study confirm earlier findings of a negative association between DRB1*13 and cervical cancer and suggest that specific DRB1-DQB1 haplotype combinations, rather than individual DQB1*03 alleles, increase the risk for cervical cancer.
|
11588129 |
2001 |
Cervix carcinoma
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
We have examined the association of variation at the DRB1 and DQB1 loci with HPV16 infection and risk of development of cervical cancer by analysis of 440 cases diagnosed with cervical cancer in situ and 476 age-matched controls in a retrospective case-control study.
|
11519043 |
2001 |
Cervix carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
In previous studies, the HLA class II haplotype HLA DRB1*0401-DQB1*0301 was shown to correlate with susceptibility to HPV infection, CIN and cervical cancer while DRB1*0101-DQB1*0501 indicated protection.
|
11562779 |
2001 |
Cervix carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
DQB1*0301 alone (2P = 0.02) and in combination with DRB1*0401 (2P = 0.02) was found to be associated with cervical cancer.
|
10755413 |
2000 |
Cervix carcinoma
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
The distribution of HLA class II DRB1 and DQB1 alleles in cervical carcinoma patients was compared with the frequency of these alleles found in healthy population living in the Czech Republic.
|
10732716 |
1999 |
Cervix carcinoma
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
The association of HLA class II DQB1 and DRB1 alleles with the development of cervical carcinoma was studied in 150 Swedish patients using PCR-based HPV and HLA typing.
|
8864172 |
1996 |